Multivariate Cox model adjusted for age, sex, and β2-microglobulin level (N = 767)
| . | No. of patients . | No of events . | aHR . | 95% CI . | P . |
|---|---|---|---|---|---|
| Treatment | |||||
| No HDM | 182 | 71 | 1 | — | — |
| VAD-HDM | 137 | 100 | 0.78 | (0.51-1.18) | .242 |
| VD-HDM | 448 | 130 | 0.59 | (0.40-0.87) | .007 |
| Translocation (4;14) | |||||
| No | 623 | 210 | 1 | — | — |
| Yes | 144 | 91 | 2.20 | (1.69-2.86) | <.001 |
| Deletion 17p | |||||
| No | 676 | 232 | 1 | — | — |
| Yes | 91 | 69 | 3.23 | (2.45-4.26) | <.001 |
| Trisomy 3 | |||||
| No | 494 | 223 | 1 | — | — |
| Yes | 273 | 78 | 0.66 | (0.48-0.91) | .011 |
| Trisomy 5 | |||||
| No | 469 | 221 | 1 | — | — |
| Yes | 298 | 80 | 0.66 | (0.47-0.93) | .017 |
| Trisomy 21 | |||||
| No | 584 | 235 | 1 | — | — |
| Yes | 183 | 66 | 1.41 | (1.02-1.96) | .040 |
| . | No. of patients . | No of events . | aHR . | 95% CI . | P . |
|---|---|---|---|---|---|
| Treatment | |||||
| No HDM | 182 | 71 | 1 | — | — |
| VAD-HDM | 137 | 100 | 0.78 | (0.51-1.18) | .242 |
| VD-HDM | 448 | 130 | 0.59 | (0.40-0.87) | .007 |
| Translocation (4;14) | |||||
| No | 623 | 210 | 1 | — | — |
| Yes | 144 | 91 | 2.20 | (1.69-2.86) | <.001 |
| Deletion 17p | |||||
| No | 676 | 232 | 1 | — | — |
| Yes | 91 | 69 | 3.23 | (2.45-4.26) | <.001 |
| Trisomy 3 | |||||
| No | 494 | 223 | 1 | — | — |
| Yes | 273 | 78 | 0.66 | (0.48-0.91) | .011 |
| Trisomy 5 | |||||
| No | 469 | 221 | 1 | — | — |
| Yes | 298 | 80 | 0.66 | (0.47-0.93) | .017 |
| Trisomy 21 | |||||
| No | 584 | 235 | 1 | — | — |
| Yes | 183 | 66 | 1.41 | (1.02-1.96) | .040 |
HDM, high-dose melphalan.